[英夫利昔单抗治疗监测在炎症性肠病治疗中的效用] - Suppr

[Usefulness of therapeutic monitoring of infliximab in the treatment of inflammatory bowel disease].

作者信息

Quera Rodrigo, Moreno Mauricio, Simian Daniela, Ibáñez Patricio, Lubascher Jaime, Figueroa Carolina, Flores Lilian, Kronberg Udo, Pizarro Gonzalo, Fluxá Daniela

机构信息

Programa Enfermedad Inflamatoria Intestinal, Clínica Las Condes, Santiago, Chile.

Laboratorio de Oncología y Genética Molecular, Unidad de Coloproctología, Clínica Las Condes, Santiago, Chile.

出版信息

Rev Med Chil. 2018 Nov;146(11):1241-1251. doi: 10.4067/S0034-98872018001101241.

DOI:10.4067/S0034-98872018001101241

PMID:30725037

Abstract

摘要

相似文献

[Usefulness of therapeutic monitoring of infliximab in the treatment of inflammatory bowel disease].[英夫利昔单抗治疗监测在炎症性肠病治疗中的效用]

Rev Med Chil. 2018 Nov;146(11):1241-1251. doi: 10.4067/S0034-98872018001101241.

Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease.英夫利昔单抗谷浓度和诱导后早期检测到的持续抗体与一过性抗体与炎症性肠病患者的长期临床缓解相关。

Dig Liver Dis. 2018 May;50(5):452-456. doi: 10.1016/j.dld.2017.11.008. Epub 2017 Nov 27.

Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease.英夫利昔单抗谷浓度及抗英夫利昔单抗抗体在儿童炎症性肠病患者中的临床应用

J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):272-278. doi: 10.1097/MPG.0000000000001258.

Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.采用新西兰检测方法评估英夫利昔单抗和阿达木单抗浓度及抗药物抗体对炎症性肠病的控制效果。

Intern Med J. 2019 Apr;49(4):513-518. doi: 10.1111/imj.14064.

Infliximab Use in a Child With Ulcerative Colitis and Prior In Utero Exposure to Infliximab.英夫利昔单抗在一名患有溃疡性结肠炎且产前曾接触过英夫利昔单抗的儿童中的应用。

Gastroenterology. 2020 May;158(6):1834-1835. doi: 10.1053/j.gastro.2020.01.002. Epub 2020 Jan 8.

Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease.测量小儿炎症性肠病患者英夫利昔单抗谷浓度及抗体的临床应用

Gut Liver. 2017 Jan 15;11(1):55-61. doi: 10.5009/gnl16041.

IMPORTANCE OF MEASURING LEVELS OF INFLIXIMAB IN PATIENTS TREATING INFLAMMATORY BOWEL DISEASE IN A BRAZILIAN COHORT.在巴西队列中测量接受炎症性肠病治疗患者的英夫利昔单抗水平的重要性。

Arq Gastroenterol. 2017 Dec;54(4):333-337. doi: 10.1590/S0004-2803.201700000-41. Epub 2017 Sep 21.

Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.先前接受过英夫利昔单抗治疗的炎症性肠病患者中硫嘌呤代谢物、阿达木单抗和针对阿达木单抗的抗体之间的相互作用。

Dig Dis Sci. 2018 Jun;63(6):1583-1591. doi: 10.1007/s10620-018-5020-9. Epub 2018 Mar 21.

Infliximab Optimization Based on Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.基于治疗药物监测的儿童炎症性肠病英夫利昔单抗优化治疗

J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):580-585. doi: 10.1097/MPG.0000000000001302.

Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experience.采用仪表盘方法优化炎症性肠病中的英夫利昔单抗治疗：印度经验。

Eur J Clin Pharmacol. 2021 Jan;77(1):55-62. doi: 10.1007/s00228-020-02975-0. Epub 2020 Aug 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Usefulness of therapeutic monitoring of infliximab in the treatment of inflammatory bowel disease].

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献